01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Casalini P, Menard S, Malandrin SM, Rigo CM, Colnaghi MI,
Cultraro CM, Segal S (1997) Inhibition of tumorigenicity in
lung adenocarcinoma cells by c-erbB-2 antisense expression.
Int J Cancer 72, 631-636.
Casciola-Rosen LA, Anhalt GJ, Rosen A (1995) DNA-dependent
protein kinase is one of a subset of autoantigens specifically
cleaved early during apoptosis. J Exp Med 182, 1625-1634.
Cassileth PA, Podack E, Sridhar K, Savaraj N, and Hanlon J
(1995) Phase I study of transfected cancer cells expressind
the interleukin-2 gene product in limited stage small cell lung
cancer. Hum Gene Ther 6, 369-383.
Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov
G, Rothblum LI (1995) Activity of RNA polymerase I
transcription factor UBF blocked by Rb gene product.
Nature 374, 177-180.
Cesano A, Visonneau S Jeglum KA, Owen J, Wilkinson K,
Carner K, Reese L, Santoli D (1996) Phase I clinical trial
with a major histocompatibility complex nonrestricted
cytotoxic T-cell line (TALL-104) in dogs with advanced
tumors. Cancer Res 56, 3021-3029.
Chadwick SL, Kingston HD, Stern M, Cook RM, O'Connor BJ,
Lukasson M, Balfour RP, Rosenberg M, Cheng SH, Smith
AE, Meeker DP, Geddes DM, Alton EW (1997) Safety of a
single aerosol administration of escalating doses of the
cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to
the lungs of normal volunteers. Gene Ther 4, 937-942.
Chambers R, Gillespie GY, Soroceanu L, Andreansky S,
Chatterjee S, Chou J, Roizman B, Whitley RJ (1995)
Comparison of genetically engineered herpes simplex viruses
for the treatment of brain tumors in a scid mouse model of
human malignant glioma. Proc Natl Acad Sci USA 92,
1411-1415.
Chan L, Teng BB, Lau P (1996) Apolipoprotein B mRNA
editing protein: a tool for dissecting lipoprotein metabolism
and a potential therapeutic gene for hypercholesterolemia. Z
Gastroenterol 34 Suppl 3, 31-32.
Chan YJ, Chiou CJ, Huang Q, Hayward GS (1996) Synergistic
interactions between overlapping binding sites for the serum
response factor and ELK-1 proteins mediate both basal
enhancement and phorbol ester responsiveness of primate
cytomegalovirus major immediate-early promoters in
monocyte and T-lymphocyte cell types. J Virol 70, 8590-
8605.
Chang AE, Sondak VK, Bishop DK, Nickoloff BJ, Mulligan RC,
and Mule JJ (1996). Clinical protocol. Adoptive
immunotherapy of cancer with activated lymph node cells
primed in vivo with autologous tumor cells transduced with
the GM-CSF gene. Hum Gene Ther 7, 773-792.
Chang EH, Jang YJ, Hao Z, Murphy G, Rait A, Fee WE Jr,
Sussman HH, Ryan P, Chiang Y, Pirollo KF (1997)
Restoration of the G1 checkpoint and the apoptotic pathway
mediated by wild-type p53 sensitizes squamous cell
carcinoma of the head and neck to radiotherapy. Head Neck
Surg 123, 507-512.
Chang JY, Xia W, Shao R, Hung MC (1996) Inhibition of
intratracheal lung cancer development by systemic delivery
of E1A. Oncogene 13, 1405-1412.
Boulikas: An overview on gene therapy
134
Chang MW, Barr E, Lu MM, Barton K, Leiden JM (1995b)
Adenovirus-mediated over-expression of the cyclin/cyclindependent
kinase inhibitor, p21 inhibits vascular smooth
muscle cell proliferation and neointima formation in the rat
carotid artery model of balloon angioplasty. J Clin Invest
96, 2260-2268.
Chang MW, Barr E, Seltzer J, Jiang Y-Q, Nabel GJ, Nabel EG,
Parmacek MS, and Leiden JM (1995a) Cytostatic gene
therapy for vascular proliferative disorders with a
constitutively active form of the retinoblastoma gene
product. Science 267, 518-522.
Chang MW, Barr E, Seltzer J, Jiang Y-Q, Nabel GJ, Nabel EG,
Parmacek MS, and Leiden JM (1995) Cytostatic gene
therapy for vascular proliferative disorders with a
constitutively active form of the retinoblastoma gene
product. Science 267, 518-522.
Chang YN, Jeang KT, Chiou CJ, Chan YJ, Pizzorno M,
Hayward GS (1993) Identification of a large bent DNA
domain and binding sites for serum response factor adjacent
to the NFI repeat cluster and enhancer region in the major
IE94 promoter from simian cytomegalovirus. J Virol 67,
516-529.
Chao J, Jin L, Chen L-M, Chen VC, and Chao L (1996) Systemic
and portal vein delivery of human kallikrein gene reduces
blood pressure in hypersensitive rats. Hum Gene Ther 7,
901-911.
Chatterjee PK and Flint SJ (1986) Partition of E1A proteins
between soluble and structural fractions of adenovirusinfected
and -transformed cells. J. Virol. 60, 1018-1026.
Chatterjee S Johnson PR, and Wong KK (1992) Dual tasrget
inhibition of HIV-1 in vitro by means of an adeno-associated
virus antisense vector. Science 258, 1485-1488.
Chellappan S, Hiebert S, Mudryj M, Horowitz J, Nevins J (1991)
The E2F transcription factor is a cellular target for the RB
protein. Cell 65, 1053-1061.
Chen BP, Fraser C, Reading C, Murray L, Uchida N, Galy A,
Sasaki D, Tricot G, Jagannath S, Barlogie B, et al (1995)
Cytokine-mobilized peripheral blood CD34 + Thy-1 + Lin -
human hematopoietic stem cells as target cells for
transplantation-based gene therapy. Leukemia 9 Suppl
1:S17-S25.
Chen C, Parangi S, Tolentino MJ, Folkman J (1995) A strategy
to discover circulating angiogenesis inhibitors generated by
human tumors. Cancer Res 55, 4230-4233.
Chen C-Y, Oliner JD, Zhan Q, Fornace Jr AJ, Vogelstein B,
Kastan MB (1994) Interactons between p53 and MDM2 in a
mammalian cell cycle checkpoint pathway. Proc Natl Acad
Sci USA 91, 2684-3688.
Chen DS, Zhu NL, Hung G, Skotzko MJ, Hinton DR, Tolo V,
Hall FL, Anderson WF, Gordon EM (1997) Retroviral
vector-mediated transfer of an antisense cyclin G1 construct
inhibits osteosarcoma tumor growth in nude mice. Hum
Gene Ther 8, 1667-1674.
Chen G, Koyama K, Yuan X, Lee Y, Zhou YT, O'Doherty R,
Newgard CB, Unger RH (1996) Disappearance of body fat in
normal rats induced by adenovirus-mediated leptin gene
therapy. Proc Natl Acad Sci USA 93, 14795-14799.